The study demonstrates high concordance between next-generation sequencing-based MSI and immunohistochemistry-based MMR measurements across more than 190,000 patients IRVING, Texas, Dec. 11, 2024 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation AI TechBio company…